Related Experiment Videos
Do drug samples influence resident prescribing behavior? A randomized trial
Richard F Adair1, Leah R Holmgren
1University of Minnesota, Minneapolis, Minn, USA. adair001@umn.edu
The American Journal of Medicine
|August 9, 2005
Summary
Access to free drug samples significantly influences resident physicians' prescribing choices, favoring advertised medications over cost-effective alternatives. This practice may impact medical education and patient expenses.
Area of Science:
- Medical Education
- Pharmacology
- Health Services Research
Background:
- Physician prescribing habits are influenced by various factors, including pharmaceutical marketing.
- Drug samples are a common marketing tool, but their impact on clinical decision-making, particularly among trainees, requires further investigation.
Purpose of the Study:
- To investigate the effect of access to free drug samples on internal medicine residents' prescribing decisions.
- To determine if drug sample availability influences the selection of advertised versus non-advertised, or expensive versus inexpensive, medications.
Main Methods:
- Prospective observational study involving 29 internal medicine residents over 6 months.
- Residents were randomized to either use or forgo free drug samples.
- Prescribing decisions for matched drug class pairs (advertised vs. non-advertised/less expensive) were analyzed.
Main Results:
- Residents with access to drug samples were significantly less likely to prescribe unadvertised drugs (P = .04).
- Access to samples also led to a decreased likelihood of choosing over-the-counter medications (P = .003).
- A trend indicated reduced selection of inexpensive drugs when samples were available.
Conclusions:
- Availability of drug samples in clinics demonstrably influences resident prescribing patterns.
- This influence may negatively impact resident education by promoting biased drug selection.
- Increased use of more expensive or advertised drugs due to sample access could lead to higher patient healthcare costs.